SCHEMBL2481389

SCHEMBL2481389

COc1ccc(C(=O)c2ccc(SCCO)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.55
MTNR1B P49286 1/20 0.55
ALDH1A1 P00352 4/20 0.55
RAB9A P51151 3/20 0.53
MAPT P10636 2/20 0.53
MEN1 O00255 1/20 0.53
LMNA P02545 1/20 0.53
MAPK1 P28482 1/20 0.53
KMT2A Q03164 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
HPGD P15428 1/20 0.53
NPC1 O15118 2/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
GAA P10253 2/20 0.49
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7207997 0.88 MTNR1A (0.57) MTNR1AMTNR1BALDH1A1RAB9AMAPT
SCHEMBL30655866 0.86 CA2 (0.53) ALDH1A1RAB9AMAPTMEN1LMNA
SCHEMBL2452199 0.82 THRA (0.54) MTNR1AMTNR1BALDH1A1RAB9AMAPT
SCHEMBL2450821 0.81 ALDH1A1 (0.57) ALDH1A1MAPTMEN1LMNAMAPK1
SCHEMBL2451174 0.81 SRD5A2 (0.58) ALDH1A1RAB9ALMNAMAPK1NPC1
SCHEMBL51274 0.80 GAA (0.54) ALDH1A1RAB9AMAPTMEN1LMNA
SCHEMBL9418310 0.78 RXFP1 (0.79) ALDH1A1RAB9AMAPTMEN1LMNA
SCHEMBL51509 0.78 RXFP1 (0.79) ALDH1A1RAB9AMAPTMEN1LMNA
SCHEMBL7611290 0.78 MAPT (0.53) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL719973 0.78 GAA (0.72) MTNR1AMTNR1BALDH1A1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS BASF SE (DE) 2026-05-14 US disclosed
EP-4709544-A1 COMPOSITIONS, COMPRISING SILVER NANOPLATELETS BASF SE (DE) 2026-03-18 EP disclosed
US-12515253-B2 Compositions, comprising silver nanoplatelets BASF SE (DE) 2026-01-06 US disclosed
US-12325806-B2 Photocurable composition for use in 3D printing BASF SE (DE) 2025-06-10 US disclosed
US-12296391-B2 Security element BASF SE (DE) 2025-05-13 US disclosed
EP-4337734-B1 COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES BASF SE (DE) 2025-04-23 EP disclosed
US-12208447-B2 Compositions, comprising silver nanoplatelets BASF SE (DE) 2025-01-28 US disclosed
EP-4490577-A1 CASTING LACQUER FOR SCREEN PRINTING BASF SE (DE) 2025-01-15 EP disclosed
WO-2024231418-A1 COMPOSITIONS, COMPRISING SILVER NANOPLATELETS BASF SE (DE) 2024-11-14 WO disclosed
CN-118891584-A Casting paint for screen printing 巴斯夫欧洲公司 2024-11-01 CN disclosed
US-20140110931-A1 PRINTING DIFFRACTION GRATINGS ON PAPER AND BOARD BASF SE (DE) 2014-04-24 US disclosed
WO-2014041121-A1 SECURITY ELEMENTS AND METHOD FOR THEIR MANUFACTURE BASF SE (DE) 2014-03-20 WO disclosed
WO-2013186167-A2 METHOD FOR MANUFACTURING SECURITY ELEMENTS AND HOLOGRAMS BASF SE (DE) 2013-12-19 WO disclosed
EP-2145231-B1 PHOTOACTIVABLE NITROGEN BASES BASF SE (DE) 2011-09-14 EP disclosed
US-20100105794-A1 PHOTOACTIVABLE NITROGEN BASES CIBA CORPORATION (US) 2010-04-29 US disclosed
EP-2145231-A1 PHOTOACTIVABLE NITROGEN BASES BASF SE (DE) 2010-01-20 EP disclosed
WO-2008119688-A1 PHOTOACTIVABLE NITROGEN BASES BASF SE (CH) 2008-10-09 WO disclosed
EP-0005530-B1 NEW MERCAPTOPHENYLKETONES AND THEIR USE AS INITIATORS FOR THE PHOTOPOLYMERISATION OF ETHYLENICALLY UNSATURATED COMPOUNDS CIBA-GEIGY AG (CH) 1982-05-12 EP disclosed
US-4297513-A Process for the preparation of benzophenone thioethers CIBA-GEIGY CORPORATION (US) 1981-10-27 US disclosed
US-4279721-A Mercaptophenyl ketones as initiators for the photopolymerization of ethylenically unsaturated compounds CIBA-GEIGY CORPORATION (US) 1981-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS COPE, COPB2, C9 MTNR1A 3714/4885MTNR1B 3555/4885ALDH1A1 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.